“Mavacamten and the Reframing of Obstructive Hypertrophic Cardiomyopathy as a Medically Treatable Disease” (2022) Journal of Heart and Cardiovascular Science, 3(1), pp. 16–21. doi:10.5281/zenodo.22344598.